157 related articles for article (PubMed ID: 35680803)
21. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
[TBL] [Abstract][Full Text] [Related]
22. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
23. Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma.
Liu X; Bai Y; Liu Y; Li W; Cui Y; Xu J; Xiao X; Niu X; Sun K
Blood Res; 2023 Dec; 58(4):187-193. PubMed ID: 38031470
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
Huang H; Fan L; Fu D; Lin Q; Shen J
Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
[TBL] [Abstract][Full Text] [Related]
25. [Value of Red Blood Cell Distribution Width and Fibrinogen Level for Evaluation of the Therapeutic Efficacy and Prognosis in Patients with Diffuse Large B-Cell Lymphoma].
Wang X; Wu CY; Zeng PY; Li LL; Ma CC; Xiang X; Li YQ; Chai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):153-159. PubMed ID: 32027269
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):671-9. PubMed ID: 26361646
[TBL] [Abstract][Full Text] [Related]
27. [The Prognostic Value of Prognostic Nutritional Index Combined with D-dimer in Patients with Diffuse Large B-Cell Lymphoma].
Han Y; Song Y; Wang Y; Jin QQ; Jiang HY; Chai Y; Zeng PY; Yue LL; Wu CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1385-1393. PubMed ID: 37846689
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer.
Yılmaz H; Yılmaz A; Demirağ G
Future Oncol; 2021 Oct; 17(29):3853-3864. PubMed ID: 34382414
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic significance of inflammatory indicators for advanced-stage diffuse large B-cell lymphoma].
Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Sun Y; Shi YK
Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1250-1255. PubMed ID: 29747314
[No Abstract] [Full Text] [Related]
30. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan KT; Melchardt T; Deutsch A; Schlick K; Stojakovic T; Bullock MD; Reitz D; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Egle A; Pichler M
Eur J Haematol; 2015 Dec; 95(6):538-44. PubMed ID: 25677782
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
32. The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer.
İlhan A; Gurler F; Yilmaz F; Eraslan E; Dogan M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2060-2067. PubMed ID: 36930504
[TBL] [Abstract][Full Text] [Related]
33. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
[No Abstract] [Full Text] [Related]
34. The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score matching analysis.
Jiang H; Jiang W; Tan L; Yu Q; Liu F; Huang Y; He J; Zhou S
J Int Med Res; 2021 Apr; 49(4):3000605211004229. PubMed ID: 33823630
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of F-18 FDG PET/CT quantization parameters for progression-free survival in patients with diffuse large B-cell lymphoma.
Xie M; Zhai W; Cheng S; Zhang H; Xie Y; He W
Hematology; 2016 Mar; 21(2):99-105. PubMed ID: 26183456
[TBL] [Abstract][Full Text] [Related]
36. The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma.
Yue W; Liu B; Gao L; He M; Wang J; Zhang W; Chen L; Hu X; Xu L; Yang J
Clin Chim Acta; 2018 Oct; 485():316-322. PubMed ID: 30006285
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.
Rahchamani M; Sedghi M; Hakimi A; Nejatianfar M; Javaheri T; Tavakoli R; Ahmadi R; Makarem M; Azmi-Naei N; Zahmatkesh Sangani S; Kamandi N; Soleimanian A; Shavaleh R; Foogerdi M; Rahmani K
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1936. PubMed ID: 37997648
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].
Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of Clinical Pathological Features and Prognosis in Young Patients with Diffuse Large B Cell Lymphoma].
Fang S; Zhao SS; Zhu CY; Yang N; Wang FY; Wang LL; Huang WR; Gao CJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):802-808. PubMed ID: 31204935
[TBL] [Abstract][Full Text] [Related]
40. Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients.
Wu XB; Hou SL; Liu H
World J Clin Cases; 2021 Nov; 9(32):9825-9834. PubMed ID: 34877321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
